-
-
-
-
-
-
-
New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®
-
-
-
-
-
-
-
Apyx Medical Corp. (APYX) Tops Q4 EPS by 6c ; Offers Guidance
-
-
-
-
-
-
-
Apyx Medical prices $10 million stock offering at $3.62 per share
-
-
-
-
-
-
-
Apyx Medical submits FDA application for AYON power liposuction expansion
-
-
-
-
-
-
-
Apyx Medical Corporation Reports Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Apyx Medical Corporation Reports First Quarter 2025 Financial Results
-
-
-
-
-
-
-
Apyx Medical Corp. (APYX) Submits FDA 510(k) Premarket Notification for AYON Body Contouring System
-
1,231,068 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


